FDA Approved: TACROLIMUS — Supplemental Application (Stellon Biotech Inc.)

View source ↗

Summary

The FDA approved Stellon Biotech Inc.'s supplemental application for tacrolimus (ANDA213112), updating the labeling for this generic immunosuppressant used to p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organ Transplant Rejection

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)